2025 HCPCS Code Q5112
Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg
| Short Description | Inj ontruzant 10 mg |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | October 01, 2023 |
| HCPCS Code Added Date | July 01, 2019 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q0513 - Disp fee inhal drugs/30 days
- Q0514 - Disp fee inhal drugs/90 days
- Q0515 - Sermorelin acetate injection
- Q0516 - Supply fee hiv prep oral 30
- Q0517 - Supply fee hiv prep oral 60
- Q0518 - Supply fee hiv prep oral 90
- Q0519 - Supply fee hiv prep inj 30
- Q0520 - Supply fee hiv prep inj 60
- Q0521 - Supply fee hiv prep fda appr
- Q1004 - Ntiol category 4
- Q1005 - Ntiol category 5
- Q2004 - Bladder calculi irrig sol
- Q2009 - Fosphenytoin inj pe
- Q2017 - Teniposide, 50 mg
- Q2026 - Radiesse injection
- Q2028 - Inj, sculptra, 0.5mg
- Q2034 - Agriflu vaccine
- Q2035 - Afluria vacc, 3 yrs & >, im
- Q2036 - Flulaval vacc, 3 yrs & >, im
- Q2037 - Fluvirin vacc, 3 yrs & >, im